Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers

Details for Australian Patent Application No. 2002343109 (hide)

Owner Oxford Glycosciences (UK) Ltd.

Inventors Terrett, Jonathan Alexander

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002343109

PCT Number PCT/GB02/05335

PCT Pub. Number WO2003/046581

Priority 60/333,436 27.11.01 US

Filing date 27 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 12 June 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/333,436 27.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002343109

12 June 2008 Application Accepted

  Published as AU-B-2002343109

9 October 2008 Standard Patent Sealed

22 October 2009 Assignment Registered

  Oxford Glycosciences (UK) Ltd The patent has been assigned to UCB Pharma S.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002343110-Imidazopyridines, pyrimidines and triazines for enhancing cognition as GABA-A alpha 5 receptor subtype ligands

2002343108-IMPROVEMENTS IN OR RELATING TO SUPPORT STRUCTURES SUITABLE FOR A MOBILE COMMUNICATIONS DEVICE